Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-17T13:41:51.845Z Has data issue: false hasContentIssue false

Demand Forecasting for Essential Medical Technologies

Published online by Cambridge University Press:  06 January 2021

Ruth Levine
Affiliation:
Center for Global Development
Jessica Pickett
Affiliation:
Center for Global Development
Neelam Sekhri
Affiliation:
The Healthcare Redesign Group
Prashant Yadav
Affiliation:
MIT-Zaragoza International Logistics Program

Extract

Today's global health programs will attain their objectives only if products appropriate to the health problems in low- and middle-income countries are developed, manufactured and made available when and where they are needed. Achieving this requires mobilizing public and charitable money for more and better products to diagnose, prevent and treat HIV/AIDS, tuberculosis, malaria, reproductive health problems and childhood killers. But more money is only one part of the story. Weak links in the global health value chain—from research and development through service delivery—are constraining on-the-ground access to essential products. The consequences of those weak links are many: supply shortages, inefficient use of scarce funding, reluctance to invest in R&D for developing country needs and, most importantly, the loss of life among those who need essential products.

Information

Type
Article
Copyright
Copyright © American Society of Law, Medicine and Ethics and Boston University 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable